Tina C. Young
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 10%
- Molecular Biology
- Cancer Research
- Co-authors
- Hossein BorghaeiScott A. LaurieScott AntoniaLaura Q.M. ChowJonathan W. GoldmanFrances A. ShepherdRosalyn A. JuergensMatthew D. Hellmann
- Topics
- Cancer Immunotherapy and Biomarkers (12 papers)Renal cell carcinoma treatment (3 papers)CAR-T cell therapy research (3 papers)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Tina C. Young
18 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Oncology 917
- Pulmonary and Respiratory Medicine 565
- Immunology 269
- Molecular Biology 139
- Cancer Research 127
Countries citing papers authored by Tina C. Young
This map shows the geographic impact of Tina C. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tina C. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tina C. Young more than expected).
Fields of papers citing papers by Tina C. Young
This network shows the impact of papers produced by Tina C. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tina C. Young. The network helps show where Tina C. Young may publish in the future.
Co-authorship network of co-authors of Tina C. Young
This figure shows the co-authorship network connecting the top 25 collaborators of Tina C. Young. A scholar is included among the top collaborators of Tina C. Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tina C. Young. Tina C. Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 76 | |
| 2 | 11 | |
| 3 | 27 | |
| 4 | 4 | |
| 5 | 14 | |
| 6 | 150 | |
| 7 | 9 | |
| 8 | 6 | |
| 9 | 14 | |
| 10 | 2 | |
| 11 | 9 | |
| 12 | Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort studybreakdown → | 700 |
| 13 | 6 | |
| 14 | 1 | |
| 15 | 21 | |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 1 |
About Tina C. Young
Tina C. Young is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 18 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Renal cell carcinoma treatment (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Oncology (917 citations), Pulmonary and Respiratory Medicine (565 citations) and Immunology (269 citations). Tina C. Young has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Hossein Borghaei, Scott A. Laurie, Scott Antonia, Laura Q.M. Chow, Jonathan W. Goldman, Frances A. Shepherd, Rosalyn A. Juergens, Matthew D. Hellmann, William J. Geese and Julie R. Brahmer. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.